 DOYLESTOWN, PA ACCESSWIRE July 20, 2021 Neuropathix, Inc. Neuropathix or the Company OTCQB:NPTX, a socially responsible pain management life sciences company, announced today the publication of the global Patent Cooperation Treaty PCT Patent under Publication No. WO2021097351 Functionalized 1,3-Benzene Diols and Their Method of Use for the Treatment of Radiation Dermatitis and Other Skin Disorders. 